November 19th 2026
–
WellBeing Magazine
–

On an 80-hectare paddock outside Lismore, something extraordinary is being grown. Something so small you need a microscope to see it properly and yet, gram for gram, it’s one of the most nutritionally dense foods on the planet.

SeaO2 Nutrition is a biotech company that started, strangely enough, in marine construction. Two of its founders, Peter Philipp and Gian Minns, were building artificial reefs and restoring coastal habitats when a bigger question surfaced: could they grow marine microalgae at scale and make it available for people to actually eat? Almost three years later, with Dr Skye Thomas-Hall (the other founder) and a dedicated science team, the answer appears to be yes.

What SeaO2 is producing in its Northern Rivers facility isn’t your average algae. SeaO2 is cultivating nannochloropsis, a marine microalga that has been used in Japan for decades and is now emerging as one of the most significant sources of omega-3 EPA on earth. It’s also working with haematococcus pluvialis, the algae that produces astaxanthin, a compound scientists are increasingly excited about for its role in healthy ageing. The fact that SeaO2 is growing both, here in regional Australia, to pharmaceutical-grade standards, is something quite remarkable.

Omega-3 defi ciency

Four out of fi ve people in the developed world don’t get the recommended daily intake of omega-3.

The health consequences of this are well documented. Omega-3 fatty acids, specifically EPA and DHA, are essential for cardiovascular health, brain function and cellular integrity. They cannot be made by the human body in any meaningful quantity; they have to come from food. And yet our modern diets, for all their variety, consistently fall short.

“Omega-3 is the biggest-selling supplement globally, and still 80 per cent of fi rst-world populations don’t get the recommended daily intake. That’s staggering. And there are so many impacts around longevity with that,” Minns explains.

For decades, the answer to this defi ciency has been fish oil. But fish oil has problems. Global fi sh stocks are under increasing pressure. Contamination with heavy metals is a legitimate concern. And the process of extracting omega-3 from fish, concentrating it and stripping out nutrients, doesn’t leave you with a particularly clean or bioavailable product.

More importantly, fish aren’t making the omega-3. They’re getting it from algae. SeaO2 is simply cutting out the middlefish.

The science here is solid. A 2024 study published in Frontiers in Nutrition found that EPA derived from nannochloropsis produced clinically meaningful reductions in both triglycerides and cholesterol in a real-world consumer population. Crucially, nannochloropsis produces EPA exclusively, without DHA, which makes it unique among natural omega-3 sources. And according to recent large-scale pharmaceutical trials, EPA-only formulations appear to outperform combined EPA and DHA treatments for cardiovascular protection

A lab unlike any other

Walking into the SeaO2 facility, you immediately understand that this is not a traditional aquaculture operation. It’s closer to a dairy or a pharmaceutical plant than anything you’d associate with seaweed farming.

The process starts in the lab. Tiny flasks of nannochloropsis culture, so fi ne that the water appears with only the faintest green tinge, are nurtured in precisely controlled conditions. Light, temperature, oxygen and carbon dioxide levels are all carefully managed. Once the cultures are strong enough, they move outside to 200-litre bags where they toughen up, exposed to the natural rhythms of sunlight and temperature. Then they scale into the big ponds.

And the ponds are genuinely extraordinary. The facility’s largest are 250 metres long and 16 metres wide, roughly fi ve Olympic swimming pools end to end, and they hold a million litres of culture. Carbon dioxide is injected through ceramic spargers that break it into microbubbles, accelerating growth. Paddle wheels keep the culture turning. In optimal conditions, the biomass can double every single day.

“Sugar cane takes a whole year to grow a crop, where in optimal conditions, we’re doubling in biomass every day,” Minns shares.

What sets SeaO2 apart from conventional cultivation isn’t just scale; it’s control. In nature, you don’t have monocultures. But when you’re growing food for human consumption, contamination management is everything. SeaO2 operates a level of monitoring and process control that goes well beyond anything done in this sector before. A centralised control system measures pH, alkalinity, temperature and optical density across the ponds, feeding data back in real time and automatically adjusting nutrient delivery to keep the cultures in their optimal state.

When nannochloropsis is in optimal condition, it actively outcompetes contaminants. When it’s not, it’s vulnerable. The entire system is designed to keep it thriving.

The red algae with remarkable potential

Alongside the nannochloropsis, SeaO2 is cultivating something that looks altogether different. Haematococcus pluvialis, when stressed, turns a vivid red. The pigment responsible is astaxanthin, and if you’ve been following the longevity science conversation, you’ve probably encountered it before.

Astaxanthin is a carotenoid produced by haematococcus as a kind of sunscreen, a survival mechanism that kicks in under stress. Under a microscope, the cells are unmistakeable: large, red orange spheres, some already dividing, some with tiny daughter cells developing inside them. The biology is fascinating, but the health implications are what’s really attracting attention.

Research shows that astaxanthin has an antioxidant activity 100 to 500 times higher than vitamin E, and around 10 times higher than other carotenoids including beta-carotene, lutein and lycopene. It crosses the blood-brain barrier, which few antioxidants can do, giving it neuroprotective properties that are under active investigation. Clinical trials have linked it to improvements in cognitive function, skin health and elasticity, inflammation markers and cardiovascular protection. It is, by a significant margin, one of the most potent antioxidants found in nature.

A 2024 review in Nutrients examined its effects on cognitive function across human clinical trials and found positive impacts on episodic memory, psychomotor function and neuroprotection. A 2025 review in ScienceDirect went further, exploring how astaxanthin may support healthy ageing through multiple biological mechanisms: mitochondrial function, epigenetic regulation, gut microbiome balance and tissue integrity. This is not a supplement making vague wellness promises. The science is increasingly specific.

SeaO2’s Chief Technology Officer, Dr Skye Thomas Hall, who has 20 years in the industry, shares: “Astaxanthin is the most potent antioxidant anti-inflammatory known. It’s been widely acknowledged for its longevity benefi ts and general cellular health.”

Retail astaxanthin extract sells for around $100,000 per kilogram. A standard capsule contains roughly six milligrams. The reason it commands that price is precisely because it’s so hard to grow well, which is exactly what makes SeaO2’s cultivation work significant. The company is currently at proof-of concept stage with haematococcus and is working to validate the astaxanthin content before moving into full production.

Processing that protects what matters

Growing algae is one thing. Turning it into something that actually retains its nutritional value is another. This is where SeaO2 diverges most sharply from traditional producers.

Traditionally, harvested algae might be transferred by truck, left in open tanks and dried in the sun, a process that introduces oxidation at every step. SeaO2 has built a closed-loop system that keeps the product away from atmospheric exposure from the moment it leaves the pond until it is fully processed and stabilised.

The harvest flows through filtration to remove contaminants, then through ultrafiltration and centrifuges to concentrate the algae from pond concentration (around 0.005 per cent) to a 20 per cent solid concentrate. UV treatment and pasteurisation kill any remaining bacteria. The product is then rapidly chilled and stored before being sent to a third-party spray dryer.

That last step, spray drying rather than freeze drying, is significant. Research conducted in partnership with the University of Queensland has shown that spray drying retains more nutrients in a more bioavailable format than freeze drying. It’s counterintuitive; most people assume freeze drying is always superior. But the data says otherwise, and SeaO2 is paying attention to the data.

The end result is a powder with an intensity you notice immediately. Vivid green, with a faintly grassy, oceanic flavour — pleasant, especially compared to some supplements on the market. Three grams a day provides close to the recommended daily intake of omega-3, alongside meaningful amounts of folate, B12 and other micronutrients that many modern diets lack.

The bigger vision

SeaO2’s ambitions extend well beyond the ponds. The business’s sister marine construction company continues its work in coastal restoration and blue carbon, specifically, efforts to re-establish mangrove habitats at scale as a carbon capture strategy. The company is working with researchers at the University of New South Wales, including a team whose lead scientist co-authored the blue carbon credit methodology with the Australian government.

Closer to home, the facility has achieved GMP accreditation (Good Manufacturing Practice, the same standard required for pharmaceutical production) and began selling product in 2025. The goal is to bring down the cost of cultivating nannochloropsis to a point where it can genuinely compete with fi sh-derived omega-3 at a consumer price point. They’re not there yet, but the infrastructure is being built.

There is also a longer dream: to create a whole-food algae oil that could replace krill oil, taking the active ingredients from both the nannochloropsis (EPA) and haematococcus (astaxanthin) and combining them into a single product. Given that krill oil is currently one of the top-selling supplements globally, and given the mounting environmental concerns around krill harvesting, the timing could hardly be better

The food future, viewed through a microscope

At SeaO2, we watched a single haematococcus cell under the highest-powered lens, red with astaxanthin, beginning to divide. In optimal conditions, one cell becomes 64. Those 64 become thousands. In the large ponds, the biomass doubles every day.

It’s a vivid illustration of what’s possible when you bring serious scientific rigour to the question of how we feed a world that’s becoming increasingly aware that modern diets are falling short. Microalgae has been part of the food chain for billions of years. SeaO2 is simply — though the word “simply” barely doesjustice to what they’re doing — finding a way to bring it to us.

Four out of five of us are omega-3 deficient. We’re getting our omega-3 from fish that are getting their omega-3 from algae, in a supply chain that is under pressure from every direction. Somewhere in a pond outside Lismore, a smarter solution is growing.

his article is featured in WellBeing Magazin 225

The post Cutting out the middlefish appeared first on WellBeing Magazine.

Read the full article here:
https://www.wellbeing.com.au/at-home/planet/cutting-out-the-middlefish.html